Bausch Health Companies BHC
NYSE BHC
$6.16 -0.26 (-4.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Revenue Growth (3y) (2012 - 2026)

Analysis

Bausch Health Companies (BHC) Revenue Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 2.22%
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn -1.40%
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 0.98%
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 9.95%
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 9.59%
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 31.67%
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 8.07%
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 75.18%
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00 -12.63%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.59%
Mar 31, 2026 9.09%
Dec 31, 2025 8.43%
Sep 30, 2025 9.43%
Jun 30, 2025 8.75%
Mar 31, 2025 5.61%
Dec 31, 2024 5.23%
Sep 30, 2024 5.94%
Jun 30, 2024 4.60%
Mar 31, 2024 2.03%
Dec 31, 2023 2.85%
Sep 30, 2023 1.54%
Jun 30, 2023 9.20%
Mar 31, 2023 -1.14%
Dec 31, 2022 -0.47%
Sep 30, 2022 -2.52%
Jun 30, 2022 -2.95%
Mar 31, 2022 -1.65%
Dec 31, 2021 1.17%
Sep 30, 2021 -0.39%